Navigation Links
World Health Assembly endorses new plan to increase global access to vaccines
Date:5/25/2012

Geneva, Switzerland May 25, 2012 Ministers of Health from 194 countries at the Sixty-fifth World Health Assembly today endorsed a landmark Global Vaccine Action Plan (GVAP), a roadmap to prevent millions of deaths by 2020 through more equitable access to existing vaccines for people in all communities.

The GVAP was coordinated by the Decade of Vaccines Collaboration, a group of leading international vaccine experts, and represents the collective vision of hundreds of global health stakeholders to extend the full benefits of immunization to all people, regardless of where they are born, who they are, or where they live.

Currently, four out of every five children receive at least a basic set of vaccinations during infancy that allow them to lead healthy, productive lives. However, this means 20 percent of children still do not benefit from basic immunization.

This comprehensive plan involves four mutually reinforcing goals: strengthening routine immunization to meet vaccination coverage targets; accelerating control of vaccine-preventable diseases with polio eradication as the first milestone; introducing new and improved vaccines; and spurring research and development for the next generation of vaccines and technologies. The plan is expected to reduce global childhood mortality, surpassing the targets of the United Nations Millennium Development Goal 4.

"The Global Vaccine Action Plan focuses on the health needs of people at all stages of life," said Dr. Flavia Bustreo, Assistant Director-General for Family, Women's and Children's Health of the World Health Organization. "The plan promotes greater coordination and synergies between immunization and other child, adolescent and reproductive health interventions leading to healthier communities everywhere."

"While immunization already prevents millions of deaths and uncounted illness, we cannot rest until life-saving, cost-effective vaccine technology reaches peop
'/>"/>

Contact: Richard Hatzfeld
Richard.Hatzfeld@sabin.org
202-294-4637
Sabin Vaccine Institute
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. New initiative aims to increase mobility for disabled children worldwide
2. Infection Causes 1 in 6 Cancers Worldwide: Study
3. Blond Genes May Vary Around the World
4. Surprising results for use of dialysis for kidney failure in developing world
5. Measles Deaths Falling Worldwide
6. Global CVD leaders call the world to action - 25 by 2025 - from the World Congress of Cardiology
7. The worlds largest heart failure congress -- Heart Failure Congress 2012
8. Canadian scientist develops worlds most advanced drug to protect the brain after a stroke
9. New real-world reassuring data from the SCAAR registry
10. Worlds Tiniest Preemies Growing Up Healthy: Report
11. Worlds tiniest preemies are growing up and doing fine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... With the swift industrial development of ... as smart phones, tablets and PDAs, a complete change ... devices are viewed these days. From only being used ... a mode for creating and delivering content while on ... , The complete makeover of this (mobile) ...
(Date:9/18/2014)... County, NY (PRWEB) September 18, 2014 ... Westchester residents, community advocates, and volunteers supported United ... annual “Best Chefs and Fine Wines” event Monday, Sept. ... United Way’s health initiatives in Westchester and Putnam, such ... obesity, and steering teens away from risky behaviors like ...
(Date:9/18/2014)... common Asian spice and cancer-hampering molecules show promise ... of the lung,s lining often linked to asbestos. ... Georg-Speyer-Haus in Frankfurt, Germany, demonstrate that application of ... cancer-inhibiting peptides increase levels of a protein inhibitor ... Their findings appeared in the Aug. 14 online ...
(Date:9/18/2014)... NC (PRWEB) September 18, 2014 October ... also Domestic Violence Awareness Month. And the Centers for ... tells a scary story. , According to the CDC ... fourth of men in the U.S. experience some form ... intimate relationship. The same survey shows that about half ...
(Date:9/18/2014)... 2014 With the arrival of subsequent-entry biologics ... Society released new resources to educate stakeholders on their potential ... guide SEB use, and patients must be well informed when ... Click here for an infographic and an expert video ... here for The Arthritis Society’s position paper on SEBs. ...
Breaking Medicine News(10 mins):Health News:Transparency Market Research: M-health Market Study 2018 2Health News:Transparency Market Research: M-health Market Study 2018 3Health News:Transparency Market Research: M-health Market Study 2018 4Health News:United Way Celebrates “Best Chefs and Fine Wines” at Sold-Out Culinary Event 2Health News:United Way Celebrates “Best Chefs and Fine Wines” at Sold-Out Culinary Event 3Health News:Curcumin, special peptides boost cancer-blocking PIAS3 to neutralize STAT3 in mesothelioma 2Health News:Curcumin, special peptides boost cancer-blocking PIAS3 to neutralize STAT3 in mesothelioma 3Health News:What you should know about domestic violence 2Health News:What you should know about domestic violence 3Health News:What you should know about domestic violence 4Health News:What you should know about domestic violence 5Health News:Subsequent-entry biologics set to alter the arthritis treatment landscape 2
... Volumizing ... ... of the eyes change in generally predictable ways: the skin thins and becomes less elastic, ... eyes appear more prominent. While surgery has long been the accepted standard and offers ...
... , COLD SPRING HARBOR, N.Y., Aug. 17 ... Doctors Laboratory (TDL), the largest independent provider of clinical laboratory ... the world,s first hand-held, non-contact vein illumination device, to the ... locate veins for blood draw (venipuncture) by projecting a pattern ...
... , ALBANY, N.Y., Aug. 17 The ... August 17, 2009, is an Air Quality Action Day, a ... such as children, seniors and people with asthma and other ... pollution. The alert is issued for the New York downstate ...
... , , MCLEAN, Va., Aug. 17 ... His Cookie Helped 500,000 People Lose Weight Fast (2009, Hyde ... at CookieDiet.com, Amazon.com, Borders.com, and BN.com; at Barnes & Noble stores ... Biggest Bookstore, and Coles. , , "Dr. Siegal,s ...
... Finding will help predict patient response to therapy, researchers say ... that predicts a patient,s response to hepatitis C treatments has ... a single letter change -- a C instead of a ... gene, according to the Duke University Medical Center team. They ...
... , PRINCETON, N.J., Aug. 17 Derma ... a provider of advanced wound care products, reports results today for the second quarter ... for second quarter and six months ended June 30, 2009: , , ... to $664,766 in second quarter 2009, versus $295,315 in 2008. For the six months ...
Cached Medicine News:Health News:Nonsurgical Technique Can Take Years Off the Appearance of Aging Eyes 2Health News:Nonsurgical Technique Can Take Years Off the Appearance of Aging Eyes 3Health News:AccuVein Sells Multiple AV300s to First European Customer 2Health News:Air Quality Action Day Declared for Monday, August 17, 2009 2Health News:Dr. Siegal's Cookie Diet Book Available at Amazon, Barnes & Noble, and Indigo Books 2Health News:Dr. Siegal's Cookie Diet Book Available at Amazon, Barnes & Noble, and Indigo Books 3Health News:Dr. Siegal's Cookie Diet Book Available at Amazon, Barnes & Noble, and Indigo Books 4Health News:Genetic Discovery May Improve Hepatitis C Treatment 2Health News:Derma Sciences Reports Second Quarter 2009 Results 2Health News:Derma Sciences Reports Second Quarter 2009 Results 3Health News:Derma Sciences Reports Second Quarter 2009 Results 4Health News:Derma Sciences Reports Second Quarter 2009 Results 5Health News:Derma Sciences Reports Second Quarter 2009 Results 6Health News:Derma Sciences Reports Second Quarter 2009 Results 7Health News:Derma Sciences Reports Second Quarter 2009 Results 8
(Date:9/18/2014)... and LONDON , ... era for biopharmaceutical companies. Competition for innovation, increasing ... to keep up with the fast-changing environment are ... influence clinical trials, and clinical trial costs continue ... patient recruitment. Studies conducted by industry ...
(Date:9/18/2014)... , Sept. 18, 2014  ADM Tronics ... DeNovi , Ph.D. to its corporate Advisory Board ... an instructor at the Harvard Medical School and ... Rome.  He received his Masters degree in Electronics ... Systems from the University of Bologna. After spending a ...
(Date:9/18/2014)... , Sept. 18, 2014 MiMedx Group, ... developer, processor and marketer of patent protected regenerative ... announced today that it has entered into a ... MiMedx will provide its dehydrated human amnion/chorion membrane ... non- exclusively on a private label basis. ...
Breaking Medicine Technology:Patient Recruitment in Asia Biotech and Pharma Companies 2Patient Recruitment in Asia Biotech and Pharma Companies 3ADM Tronics Appoints Gianluca DeNovi, Ph.D. To Advisory Board 2ADM Tronics Appoints Gianluca DeNovi, Ph.D. To Advisory Board 3MiMedx Signs Distribution Agreement With Zimmer 2MiMedx Signs Distribution Agreement With Zimmer 3
... and secondary endpoints of,study; no negative drug-drug ... CAMBRIDGE, Mass., June 12, 2007 /PRNewswire-FirstCall/ -- ... phase II study,designed to evaluate triple combination ... candidate for the,treatment of hepatitis C, pegylated ...
... II Study Demonstrates Significant,Additional Improvement for Patients ... /PRNewswire-FirstCall/ --,Indevus Pharmaceuticals, Inc. today announced that ... for pagoclone in persistent,developmental stuttering will be ... the New Clinical Drug Evaluation Unit (NCDEU), ...
Cached Medicine Technology:Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 2Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 3Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 4Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 5Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 6Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 2Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 3Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 4Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 5Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 6Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 7Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 8Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 9
Resorbable fixation system 1.5/2.0....
... Sonomed-315 is intended for visualization of the ... midline shifts in the brain, evaluation of ... to use, the Sonomed-315 offers quick and ... allows to identify the anatomic structures of ...
... cost, low volume alternative. Whole blood is drawn ... from whole blood by centrifugation in a standard ... Cebus single use cartridge. The cartridge is then ... the concentrating process. Finally, the cartridge is spun ...
Exclusive oxidized regenerated cellulose technology. The only oxidized regenerated cellulose hemostat line, surgicel absorbable hemostat delivers a unique combination of effectiveness, absorbability,...
Medicine Products: